Clinical evaluation of two phacoemulsification tips: 23G phacoemulsification tip in comparison to 20G CMP phacoemulsification tip

ISRCTN ISRCTN72610588
DOI https://doi.org/10.1186/ISRCTN72610588
Secondary identifying numbers 690/2007
Submission date
12/06/2012
Registration date
10/08/2012
Last edited
12/06/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Eye Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Cataracts are cloudy patches that develop in the lens of the eye and can cause blurred or misty vision. Phacoemulsification cataract surgery is a procedure in which an ultrasonic device is used to break up and then remove a cloudy lens from the eye to improve vision. An artificial intraocular lens is then inserted into the eye. Modern micro-incision cataract surgery aims to reduce the size of the incision needed for the surgery by using smaller intraocular lenses and phacoemulsification tips. This may result in less operative trauma. The aim of this study is to compare a 23 gauge (G) phacoemulsification tip to a conventional 20G phacoemulsification tip for micro-incision cataract surgery.

Who can participate?
Patients aged 55-88 with age-related bilateral cataracts (i.e., in both eyes) and scheduled to undergo bilateral cataract surgery at our hospital.

What does the study involve?
A conventional 23G phacoemulsification tip will be used for the cataract surgery in one eye, while in the other eye cataract surgery will be performed with a 20G phacoemulsification tip. The follow-up care will be at our hospital. Visits will be 1 week and 6 months after surgery. The visits will include standard postoperative care and a measurement of the cornea of the eye.

What are the possible benefits and risks of participating?
Cataract operations are generally very successful, with a low risk of serious complications. We do not expect any additional risk due to participation in the study. There may be no direct benefits for the participants, but the smaller incisions used for the 23G tip may lead to a faster recovery.

Where is the study run from?
Medical University of Vienna (Austria).

When is the study starting and how long is it expected to run for?
The study ran from April 2008 to April 2011.

Who is funding the study?
Medical University of Vienna (Austria).

Who is the main contact?
Dr Rupert Menapace
rupert.menapace@meduniwien.ac.at

Contact information

Dr Rupert Menapace
Scientific

Department of Ophthalmology
Medical University of Vienna
Waehringer Guertel 18-20
Vienna
1090
Austria

Email rupert.menapace@meduniwien.ac.at

Study information

Study designProspective randomised single-masked clinical trial with within-patient comparison
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleClinical evaluation of two phacoemulsification tips: 23G phacoemulsification tip in comparison to 20G CMP phacoemulsification tip - a randomised trial
Study objectivesTo compare the intraoperative efficiency, safety and postoperative outcomes after cataract surgery with two different phacoemulsification tips - 23G phacoemulsification tip for co-axial higher-fluidics phacoemulsification compared to CMP 20G phacoemulsification tip for co-axial lower-fluidics phacoemulsification.
Ethics approval(s)The Ethics Committee of the Medical University of Vienna (Borschkegasse 8b/E 06, A-1090 Vienna, Austria), 13/03/2007, EK-Nr.: 690/2007
Health condition(s) or problem(s) studiedCataract surgery
InterventionCataract surgery will be performed under topical anaesthesia through a 3.0 mm temporal self-sealing sclero-corneal tunnel incision. In all techniques, the Anterior Continuous Curvilinear Capsulorhexis (ACCC) with appropriate overlap of the intraocular lens (IOL) optic will be created using a needle. Thereafter hydrodissection, phacoemulsification and irrigation/aspiration of the lens will be performed.

In randomised order, cataract surgery with a 23G phacoemulsification tip will be performed in one eye; in the fellow eye cataract surgery will be performed with the 20G phacoemulsification tip.
Intervention typeOther
Primary outcome measure1. Phacoemulsification time (sec)
2. Maximum phacoemulsification power (%)
Secondary outcome measures1. Overall surgery time (min)
2. Length of corneal incision (mm)
3. Stability of anterior chamber
4. Corneal stress (semiquantitatively)
5. Anterior chamber flare measurement (LFCM)
6. Corneal endothelial cell count
7. Pachymetry
8. Corneal topography and keratometry
Overall study start date01/04/2008
Completion date01/04/2011

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants50 patients (100 eyes)
Key inclusion criteria1. Patients with age-related cataracts in both eyes awaiting bilateral same-day cataract surgery
2. Age range: 55 - 88 years, both male and female
Key exclusion criteria1. Anamnesis or clinical signs of uveitis
2. Glaucoma
3. Proliferative diabetic retinopathy
4. Trauma
5. Small pupil
6. Previous ophthalmic operation
Date of first enrolment01/04/2008
Date of final enrolment01/04/2011

Locations

Countries of recruitment

  • Austria

Study participating centre

Department of Ophthalmology
Vienna
1090
Austria

Sponsor information

Medical University of Vienna (Austria)
Hospital/treatment centre

Medical University of Vienna
Waehringer Guertel 18-20
Vienna
1090
Austria

ROR logo "ROR" https://ror.org/05n3x4p02

Funders

Funder type

Hospital/treatment centre

Medical University of Vienna (Austria)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan